(Q40766085)

23 September 2017

Surfactant protein A (SP-A)-mediated bacterial clearance: SP-A and cystic fibrosis (English)

1 reference

23 September 2017

0 references

Korfhagen TR

1

1 reference

23 September 2017

1 December 2001

1 reference

American Journal of Respiratory Cell and Molecular Biology

23 September 2017

1 reference

23 September 2017

25

1 reference

23 September 2017

6

1 reference

23 September 2017

668-672

1 reference

Antibiotic peptides from higher eukaryotes: biology and applications

23 September 2017

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.6.F221

Chinks in the armor of the airway: Pseudomonas infection in the cystic fibrosis lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.6.F221

Antimicrobial peptides as mediators of epithelial host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.6.F221

Organization of the human SP-A and SP-D loci at 10q22-q23. Physical and radiation hybrid mapping reveal gene order and orientation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.6.F221

Characterization of the mouse collectin gene locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.6.F221

Interactions of surfactant protein D with pathogens, allergens and phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.6.F221

Collectins and pulmonary host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.6.F221

Surfactant Proteins A and D and Pulmonary Host Defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.6.F221

Surfactant Protein A: regulation of innate and adaptive immune responses in lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.6.F221

Surfactant protein A (SP-A): the alveolus and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.6.F221

The pulmonary collectins and surfactant metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.6.F221

Pulmonary collectins and innate host defense of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.6.F221

Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.6.F221

Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.6.F221

Aggregation and opsonization of type A but not type B Hemophilus influenzae by surfactant protein A

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.6.F221

Surfactant protein a promotes attachment of Mycobacterium tuberculosis to alveolar macrophages during infection with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.6.F221

Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages by production of peroxynitrite

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.6.F221

The comparative toxicity of nitric oxide and peroxynitrite to Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.6.F221

Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.6.F221

Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.6.F221

Effects of surfactant protein A and NaCl concentration on the uptake of Pseudomonas aeruginosa by THP-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.6.F221

Decreased surfactant protein A in patients with bacterial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.6.F221

Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.6.F221

Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.6.F221

Elemental composition of human airway surface fluid in healthy and diseased airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.6.F221

Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.6.F221

Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease-control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.6.F221

Noninvasive in vivo fluorescence measurement of airway-surface liquid depth, salt concentration, and pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.6.F221

Surfactant protein D stimulates phagocytosis of Pseudomonas aeruginosa by alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.25.6.F221

21 January 2018

Identifiers

DOI

10.1165/AJRCMB.25.6.F221

1 reference

23 September 2017

1 reference

PubMed ID

11726390